That New Alzheimer’s Drug? Don’t Get Your Hopes Up Yet by BY GINA KOLATA


After declaring aducanumab a failure, the manufacturer now says the drug may help slow cognitive decline in certain patients. Some experts are skeptical.

Published: October 22, 2019 at 10:48PM

from NYT Health https://ift.tt/2MZm4JG